BIOLASE Inc news

   Watch this stock
Showing stories 1 - 10 of about 102   

Articles published

BIOL 2.50 -0.01 (-0.40%)
price chart
Biolase management overhauled amid bid to stanch a decade of red ink
Biolase Inc., a manufacturer and distributor of dental lasers, is pinning its turnaround hopes on a new management team. Biolase develops, manufactures and markets laser systems that are used in dental procedures.
Related articles »  
Oracle Partners Decisively Wins Shareholder Litigation Against Biolase, Inc.
GREENWICH, Conn., Jun 13, 2014 (BUSINESS WIRE) -- Oracle Partners, L.P. ("Oracle Partners"), Biolase, Inc.
Related articles »  
BIOLASE Inc (BIOL): Biolase: Management's Statements At Odds With The Facts
Management of Biolase (NASDAQ:BIOL) has repeatedly tried to mask bad news through the use of euphemistic and creative wording in disclosures and press releases.
Related articles »  
Oracle Partners Announces Its Proxy Contest Against Biolase, Inc.
GREENWICH, Conn., March 11, 2014 /PRNewswire/ -- Oracle Partners, L.P. ("Oracle"), Biolase, Inc.'s ("Biolase" or the "Company") (Nasdaq: BIOL) largest shareholder, announces its nomination of four independent directors for election to the Biolase Board ...
Related articles »  
BIOLASE Inc (BIOL): Biolase: What Will Happen Next ?
Two days ago I highlighted an ongoing plunge that had already begun at Biolase (NASDAQ:BIOL). Prior to my article, the shares had already dropped by 50% in a few days due to the markets' concern over Biolase's solvency and an upcoming financing.
Related articles »  
Healthcare Stocks In The Spotlight: BIOLASE, (NASDAQ:BIOL), AmSurg ...
BIOLASE, Inc. (NASDAQ:BIOL)'s shares picked up 5.85%, and closed at $2.17, during the last trading session, soon after the news release that a medical technology company, introduced dentistry's first-ever Practice Growth Guarantee with the launch of ...
BIOLASE Announces Management Change
IRVINE, Calif.--(BUSINESS WIRE)--BIOLASE, Inc. (NASDAQ:BIOL), the world's leading manufacturer and distributor of dental lasers, today reported that Frederick D. Furry has resigned as Chief Financial Officer, effective January 31, 2015 to pursue other ...
BIOLASE Names David C. Dreyer Chief Financial Officer
IRVINE, Calif.--(BUSINESS WIRE)--BIOLASE, Inc. (NASDAQ:BIOL), the global leader in dental lasers, today announced that it has hired veteran financial executive David C. Dreyer as its Chief Financial Officer.
Biolase CEO Optimistic After Tumultuous Year
IRVINE, Calif., March 5, 2015 - The head of Biolase Inc. said he is confident the dental laser firm will grow in the new year after enduring a tumultuous 2014.
Biolase Report Could Presage Growth  Orange County Business Journal
BIOLASE Stock Price Down 5.7% After Earnings Miss (BIOL)  Dakota Financial News
Oracle Partners Announces a Victory in Shareholder Litigation Against Biolase ...
GREENWICH, Conn., May 30, 2014 /PRNewswire/ -- Oracle Partners, L.P. ("Oracle Partners"), Biolase, Inc.'s ("Biolase" or the "Company") BIOL, +5.26% largest shareholder, announced that it has won a significant victory in its shareholder litigation ...
Update on Biolase - Oracle Partners fight for control (BIOL)  Seeking Alpha
Related articles »